Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...

A lawsuit against genomics firm 23andMe is stirring a debate about what the proper role of government is in regulating how ...

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...

Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.

The clock is ticking and you only have a few weeks left to file a claim and get part of the 23andMe class-action settlement.

The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing ...

旧金山 - 目前市值为1.4927亿美元的基因检测公司23andMe Holding Co. (OTC: MEHCQ)周五宣布，已与公司联合创始人Anne Wojcicki领导的非营利组织TTAM Research Institute达成最终协议，以3.05亿美元出售其绝大部分资产。根据 InvestingPro 数据显示，该公司在过去十二个月面临重大财务挑战，EBITDA为-1.6489亿美元。

Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of ...

Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a ...

TTAM Research Institute, a non-profit public benefit company also founded by Wojcicki, won the auction with a $305 million ...

The co-founder of bankrupt genetic analysis company 23andMe won an auction for the firm’s assets, agreeing, along with a ...

DNA data saved: 23andMe co-founder Anne Wojcicki has bid $305 million through a nonprofit to acquire her bankrupt company, ...